Your browser doesn't support javascript.
loading
Epidemiology of male osteoporosis in Denmark (1996-2018).
Bruhn, Rasmus; Pedersen, Alma Becic; Heide-Jørgensen, Uffe; Ehrenstein, Vera.
Affiliation
  • Bruhn R; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
  • Pedersen AB; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
  • Heide-Jørgensen U; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
  • Ehrenstein V; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark. ve@clin.au.dk.
Osteoporos Int ; 34(5): 935-942, 2023 May.
Article in En | MEDLINE | ID: mdl-36912928
ABSTRACT
Osteoporosis in men may be underdiagnosed. One in four men in Denmark will develop osteoporosis after age of 50 years, with fracture as a common presenting symptom.

PURPOSE:

The aim of this study was to describe epidemiology of male osteoporosis in Denmark.

METHODS:

In this nationwide registry-based cohort study, we identified men with osteoporosis, 50 years or older, residing in Denmark, during the years 1996-2018. Osteoporosis was defined as one of the following a hospital diagnosis of osteoporosis; a hospital diagnosis of osteoporosis fracture; or an outpatient dispensing of an anti-osteoporosis medication. We reported annual incidence and prevalence and described the distribution of fractures, comorbidities, socioeconomic status, and initiation of anti-osteoporosis therapy among men with osteoporosis. Selected characteristics were also described among men without osteoporosis of similar age.

RESULTS:

There were 171,186 men fulfilling the study criteria for osteoporosis. The overall age-standardized incidence rate of osteoporosis was 8.6 per 1000 person-years (95% confidence interval (CI), 8.5-8.6), varying between 7.7 and 9.7, while the prevalence increased from 4.3% (95% CI, 4.2-4.3) to 7.1% (95% CI, 7.0-7.1) during the 22-year period. The remaining-lifetime risk of developing osteoporosis after age of 50 years was close to 30%. The proportion of men initiating anti-osteoporosis treatment within 1 year of diagnosis increased from 6.9% to 29.8%. Men with osteoporosis had more comorbidities and redeemed more medication than did men without osteoporosis of similar age.

CONCLUSION:

Osteoporosis among men may be undertreated despite increasing treatment initiation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Osteoporotic Fractures / Hip Fractures Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Osteoporos Int Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Osteoporotic Fractures / Hip Fractures Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Osteoporos Int Year: 2023 Document type: Article